Screener
Oruka Therapeutics, Inc. ORKA Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:01 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001213900-26-055769
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Other income (expense): | ||
| Interest income | 4,606 | 4,092 |
| Other income (expense), net | 8 | (5) |
| Total other income, net | 4,614 | 4,087 |
| Net loss | $(31,820) | $(20,999) |
| Net loss per share attributable to common stockholders, basic and diluted | $(0.48) | $(0.40) |
| Net loss per share attributable to Series B non-voting convertible preferred stockholders, basic and diluted | $(39.81) | $(32.95) |
| Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted | 55,172,410 | 41,679,560 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Oruka Therapeutics, Inc.'s other income (expense)?
- Oruka Therapeutics, Inc. (ORKA) reported other income (expense) of $4.61M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s other income (expense) changed year-over-year?
- Oruka Therapeutics, Inc.'s other income (expense) increased by 12.9% year-over-year, from $4.09M to $4.61M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Oruka Therapeutics, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude